February’s top news stories
Eidos Therapeutics commenced a pivotal Phase III clinical trial of its investigational small molecule AG10...
Eidos Therapeutics commenced a pivotal Phase III clinical trial of its investigational small molecule AG10...
Janssen Pharmaceutical Companies of Johnson & Johnson unblinded the Phase III TITAN trial investigating Erleada...
The US National Institutes of Health (NIH) has provided funding for a clinical trial to...